Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Services-Home Health Care Services

Option Care Health, Inc. to acquire Amedisys Inc

Announced May 3, 2023 · Terminated Jun 26, 2023

Deal value$3.60BEV $3.56B
Premium26.0%To unaffected price
EV / Adj. EBITDA15.8x
ConsiderationAll stock$97.38 per share

Transaction

Acquirer
Option Care Health, Inc. (OPCH)
Target
Amedisys Inc (AMED)
Buyer type
Strategic
Offer price per share
$97.38
Enterprise value
$3.56B
Status
Terminated Jun 26, 2023

Deal protections

Break fee (target pays)
$125M · 3.5%
Reverse fee (buyer pays)
$250M · 6.9%
Go-shop
No-shop
Financing
No financing condition

Advisors

To the acquirer
Goldman Sachs
To the target
Guggenheim

Sector context · Healthcare

Comparable deals
80 in the prior 24 months
Premium
26.0% vs. 50.0% sector median
EV / Adj. EBITDA
15.8x vs. 21.1x sector median
Break fee
3.5% vs. 3.5% sector median

Timeline

  1. AnnouncedMay 3, 2023
  2. TerminatedJun 26, 2023
Sources
  • 8-K (EX-99.1) · May 3, 2023

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.